HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition
- 25 January 2020
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 245, 117354
- https://doi.org/10.1016/j.lfs.2020.117354
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (61671098, 31560312, 201807010003)
This publication has 29 references indexed in Scilit:
- The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGFCarcinogenesis: Integrative Cancer Research, 2014
- Uncovering the role of p53 splice variants in human malignancy: a clinical perspectiveOncoTargets and Therapy, 2013
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1Cell, 2012
- Interaction of Hepatitis B Viral Oncoprotein with Cellular Target HBXIP Dysregulates Centrosome Dynamics and Mitotic Spindle FormationOnline Journal of Public Health Informatics, 2008
- HBXIP, Cellular Target of Hepatitis B Virus Oncoprotein, Is a Regulator of Centrosome Dynamics and CytokinesisCancer Research, 2006
- Human ATP‐dependent RNA/DNA helicase hSuv3p interacts with the cofactor of survivin HBXIPThe FEBS Journal, 2005
- HBXIP functions as a cofactor of survivin in apoptosis suppressionThe EMBO Journal, 2003
- Mammalian DNA Mismatch RepairAnnual Review of Genetics, 1999